SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004072
Filing Date
2021-11-10
Accepted
2021-11-10 16:06:52
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vor-20210930.htm   iXBRL 10-Q 2912979
2 EX-10.1 vor-ex10_1.htm EX-10.1 54510
3 EX-31.1 vor-ex31_1.htm EX-31.1 18030
4 EX-31.2 vor-ex31_2.htm EX-31.2 18034
5 EX-32.1 vor-ex32_1.htm EX-32.1 21530
  Complete submission text file 0000950170-21-004072.txt   7998690

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vor-20210930_cal.xml EX-101.CAL 36881
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vor-20210930_lab.xml EX-101.LAB 321881
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vor-20210930.xsd EX-101.SCH 37714
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vor-20210930_def.xml EX-101.DEF 132378
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vor-20210930_pre.xml EX-101.PRE 235979
11 EXTRACTED XBRL INSTANCE DOCUMENT vor-20210930_htm.xml XML 1314395
Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39979 | Film No.: 211396559
SIC: 2836 Biological Products, (No Diagnostic Substances)